BSL Intrinsic Value
BSL (BSL) median intrinsic value is ₹119.00 from 8 valuation models (range ₹36–₹301), vs current price ₹120.48 — -1.2% downside (Trading Near Calculated Value), margin of safety -1.2%. For current market price and key ratios, visit BSL company profile.
BSL Valuation Methods Summary — DCF, Graham Number & P/E
BSL intrinsic value across 8 models vs current price ₹120.48 — upside/downside and value range per method. Browse BSL complete financial for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹42.00 | ₹33.60 - ₹50.40 | -65.1% | EPS: ₹3.50, Sector P/E: 12x |
| Book Value Method | asset | ₹119.00 | ₹107.10 - ₹130.90 | -1.2% | Book Value/Share: ₹119.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹240.96 | ₹216.86 - ₹265.06 | +100.0% | Revenue/Share: ₹665.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹240.96 | ₹216.86 - ₹265.06 | +100.0% | EBITDA: ₹52.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹301.20 | ₹240.96 - ₹361.44 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹36.14 | ₹32.53 - ₹39.75 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹36.14 | ₹32.53 - ₹39.75 | -70.0% | Revenue Growth: 11.1%, Adj P/E: 8.4x |
| Graham Defensive Method | conservative | ₹96.81 | ₹87.13 - ₹106.49 | -19.6% | EPS: ₹3.50, BVPS: ₹119.00 |
BSL Intrinsic Value vs Market Price — All Valuation Models
BSL fair value range ₹36–₹301 vs current market price ₹120.48 across 8 valuation models. Compare with BSL fair value to assess whether the stock is under or overvalued.
BSL Intrinsic Value Analysis — Undervalued or Overvalued?
BSL median intrinsic value ₹119.00, current price ₹120.48 — Trading Near Calculated Value by 1.2%, margin of safety -1.2%.
What is the intrinsic value of BSL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of BSL (BSL) is ₹119.00 (median value). With the current market price of ₹120.48, this represents a -1.2% variance from our estimated fair value.
The valuation range spans from ₹36.14 to ₹301.20, indicating ₹36.14 - ₹301.20.
Is BSL undervalued or overvalued?
Based on our multi-method analysis, BSL (BSL) appears to be trading near calculated value by approximately 1.2%.
BSL Financial Health — Key Ratios vs Industry Benchmarks
BSL financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.57 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.06x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
BSL Cash Flow Quality — Operating & Free Cash Flow
BSL operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹57 Cr | ₹52 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-40 Cr | ₹-50 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹19 Cr | ₹-61 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹3 Cr | ₹-5 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹17 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |